Zoznam 
 Predchádzajúci 
 Nasledujúci 
 Úplné znenie 
Postup : 2018/2775(RSP)
Postup v rámci schôdze
Postup dokumentu : B8-0071/2019

Predkladané texty :

B8-0071/2019

Rozpravy :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Hlasovanie :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Vysvetlenie hlasovaní

Prijaté texty :

P8_TA(2019)0113

Rozpravy
Streda, 13. februára 2019 - Štrasburg Revidované vydanie

16.11. Používanie konope na liečebné účely (B8-0071/2019) (hlasovanie)
Videozáznamy z vystúpení
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Posledná úprava: 24. mája 2019Právne upozornenie - Politika ochrany súkromia